Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Psychosis TMS Study

NCT: NCT05857137 · ACTIVE_NOT_RECRUITING

NCT IDNCT05857137
StatusACTIVE_NOT_RECRUITING
Start Date2023-04-04
Completion2027-06-30
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields applied over the surface of the scalp.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑